Member Info for ShareSting

Richard
This board attracts some strange virus. Just as well SNG001 is suitable across many viral infections. A few sprays on this chatroom will soon kill them off :-)

It’s good to see the company active on their Social Media.

Andrew’s trying to line up an interview with Richard this PM. Not 100% confirmed yet !

Interesting article in the Times today on Acacia Research.
It clear they have continued their clearance of SNG shares. Combine that with Lansdowne and Griff, boy we have had some head wind. Lansdowne are in deep trouble and continue to clear a number of stocks.

The one thing that keeps me positive is the strength of the news. It just keeps getting better. Today’s RNS is a fantastic step forward. I expect some headlines this weekend.

Only 9 trading days to July. Not long now for COPD results.

Now is our time to spread the word to our friends and family. This amazing treatment (in my eyes) is now available for all to benefit.
I have let my parents and in-laws know and told them to tell their friends and family. News will spread quickly.

In summary little Synairgen are doing an amazing job. They have had to design and have protocols signed off by MHRA to achieve this trial. Well done Richard and the team !

So where is Matt Han**** this morning, why is he not out actively pushing the National At Home trials ?

I just received a response from my MP in record time.
He said he will do his best to raise awareness and raise my email with the relevant Ministry

Sooner they clear the better !!

This is huge news.
We have a National At Home Study. If this doesn’t make the headlines nothing will. First ever in UK. Fantastic job by Richard and the team at Southampton!

Now we need national press coverage to raise awareness. Start contacting press !!!

If Richard and the team have any chance of applying for emergency drug approval through MHRA and or FDA they need as much evidence as possible.
If you work in the medical industry you will know there is a window of opportunity for treatments to be approved on the emergency footing. You will also know you will need significant evidence. Market surveillance will also support the application, so all the evidence of Interferon working well against C-19 will add value.

For me COPD stand alone results are major (just read the Sept19 RNS (pr C-19)). However COPD is equally important to support C-19 data. We also have the Asthma data to overlay that. So actual patient numbers add up over all four / five data sets.

Just my thinking.

Not sure if this will GAP UP on its own.
It would require news.
Personally I would be glad to see it break 40p and hold.

Promotion to Sherif thanks... You I wasn’t alone to notice your sudden mood swings... I guess you are balancing your positivity with negativity... interesting strategy.

Looks like we could hit 4m today.. that should clear a few more Lansdowne/ Acacia. Bring on 40p+.... ohh positivity again.... gzzz

No I puss always rely on you for a subtle de-ramp.
I guess you have sold and looking to buy back cheaper again.
Personally I’m invested here based on what I see as a ethnically minded BOD with no leaks. Unlike some AIM companies.

As you remind me all the time, expect the unexpected, keep balance and don’t listen or invest based on anyone’s positivity or equally negatively/ sudden mood changes ;-)

Looks like the 10% traders have been selling, I wish I could play their game. 10% a day soon adds up.
Hopefully there done and we can attack 40p later this PM.
GLA. Catch up later.

Yet again MM’s holding this below 40p.
You get a feeling once 40p goes 50p will come around quickly.
Positive COPD news has to be worth £400m partnership deal on its own.
Dragon information is limited. Hence asking the PR team for detail.

I have dropped a message to Sue and Olivia at Consillium asking why they are not pushing this news through a RNS and Social !

I will let you know if they respond.

Let’s be clear. The company has not published the cost of SNG001. Anyone pointing to a made up number is misleading the board. We simply do not know.

As for side effects, we know they are much reduced when delivered by nebuliser.

COPD and Asthma data shows product is safe. Along with commentary from CEO and our Prof

I personally invested based in Asthma and COPD data alone. All additional studies into Interferon are a bonus.

Prof Tim has mentioned side effects of SNG001 in past comments on Asthma and COPD data. We know that there is extremely low risk of side effects, especially when compared to injection.

As for Dex drug it can have some real nasty side effects. But if it saves 1 in 8 from death, I guess it is worth a go.

As for SNG001 as mentioned. 1-8 is being called wonder drug. Just imagine what SNG001 is called if it prevents the hospital trip altogether!

Just read the side effects of the new wonder drug.
Sky news list them.... all I will say is I truly hope SNG001 prevents people from having to use it.

Bring on the news !

So tonight we hear 1 in 8 benefit is a huge success story.
So is that the benchmark set for hospital trials ?
There test did t even have a placebo.

More asking for thoughts !